Aligos Therapeutics, Inc.
ALGSNasdaqCIK 1799448HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0216:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058256 |
| 2023-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006671 |
| 2023-10-2517:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-263158 |
| 2023-10-1808:45 ET | 8-K | 8.01 Other events | 0001193125-23-258115 |
| 2023-09-0716:01 ET | 8-K | 3.01 Delisting notice | 0001193125-23-230611 |
| 2023-08-0316:21 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038045 |
| 2023-08-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-004975 |
| 2023-08-0116:52 ET | 8-K | 8.01 Other events | 0001193125-23-200617 |
| 2023-07-2516:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-193424 |
| 2023-05-0416:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017890 |
| 2023-05-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-002889 |
| 2023-04-2816:47 ET | DEF 14A | Proxy statementPeriod 2023-07-20 | 0001193125-23-127382 |
| 2023-03-0916:14 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007033 |
| 2023-03-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-001548 |
| 2022-11-0216:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021248 |
| 2022-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-007002 |
| 2022-08-0416:40 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014815 |
| 2022-08-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-005357 |
| 2022-06-2716:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-182802 |
| 2022-05-0416:31 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007407 |
| 2022-05-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-003216 |
| 2022-04-2906:08 ET | DEF 14A | Proxy statementPeriod 2022-06-23 | 0001193125-22-129730 |
| 2022-03-3021:30 ET | 8-K | 8.01 Other events | 0001193125-22-088448 |
| 2022-03-2208:23 ET | 8-K | 8.01 Other events | 0001193125-22-081126 |
| 2022-03-1016:14 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003365 |
| 2022-03-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-001773 |
| 2022-01-3116:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-023399 |
| 2022-01-0608:11 ET | 8-K | 8.01 Other events | 0001193125-22-003165 |
| 2021-11-1816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-333831 |
| 2021-11-0416:23 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-054514 |
| 2021-11-0416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-007561 |
| 2021-08-0516:38 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-041653 |
| 2021-08-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-005574 |
| 2021-06-2816:01 ET | S-1 | Registration statement | 0001193125-21-201893 |
| 2021-06-2417:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-198812 |
| 2021-06-2417:03 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-21-198804 |
| 2021-06-2116:44 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-195170 |
| 2021-06-2116:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-195127 |
| 2021-05-1016:21 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026071 |
| 2021-05-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-003344 |
| 2021-05-0316:57 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-148141 |
| 2021-04-2716:15 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001193125-21-134253 |
| 2021-04-2716:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-134238 |
| 2021-03-2316:26 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-014872 |
| 2021-03-2316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-001999 |
| 2020-11-2517:21 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001193125-20-303749 |
| 2020-10-3016:25 ET | SC 13D | Ownership report, active investor | 0001193125-20-282616 |
| 2020-10-2216:31 ET | SC 13D | Ownership report, active investor | 0001193125-20-274431 |
| 2020-10-2016:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-272852 |
| 2020-10-0917:26 ET | S-1/A | Registration statement, amended | 0001193125-20-267346 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:13 ET. Listed shows no prices and gives no investment advice.